Pentoxifylline in Acute Nonhemorrhagic Stroke

Completed

Phase 2 Results

Results

Neurologic deficit scores improved from baseline admission scores during the 4-week study in both groups but did not differ between groups at admission or throughout the study except during the first few days. There were no differences in mortality of functional deficit between treatment groups.